Search Results

There are 3683 results for: content related to: Long-term outcomes of second treatment after initial transarterial chemoembolization in patients with hepatocellular carcinoma

  1. You have free access to this content
    Poster Session 1: Cellular Immunobiology, Preservation, and Cell Transplantation in Transplant; Clinical: Hepatocellular Carcinoma and Cholangiocarcinoma

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 380A–456A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28212

  2. You have free access to this content
    Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma

    Cancer

    Volume 118, Issue 1, 1 January 2012, Pages: 147–156, Julien Edeline, Eveline Boucher, Yan Rolland, Elodie Vauléon, Marc Pracht, Christophe Perrin, Catherine Le Roux and Jean-Luc Raoul

    Version of Record online : 28 JUN 2011, DOI: 10.1002/cncr.26255

  3. You have free access to this content
    Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma

    Hepatology

    Volume 62, Issue 4, October 2015, Pages: 1111–1121, Adeel R. Seyal, Fernanda D. Gonzalez-Guindalini, Atilla Arslanoglu, Carla B. Harmath, Robert J. Lewandowski, Riad Salem and Vahid Yaghmai

    Version of Record online : 19 JUN 2015, DOI: 10.1002/hep.27915

  4. mRECIST response combined with sorafenib-related adverse events is superior to either criterion alone in predicting survival in HCC patients treated with TACE plus sorafenib

    International Journal of Cancer

    Volume 140, Issue 2, 15 January 2017, Pages: 390–399, Wenjun Wang, Wei Bai, Enxin Wang, Yan Zhao, Lei Liu, Man Yang, Hongwei Cai, Dongdong Xia, Lei Zhang, Jing Niu, Zhanxin Yin, Zhuoli Zhang, Daiming Fan, Jielai Xia and Guohong Han

    Version of Record online : 17 OCT 2016, DOI: 10.1002/ijc.30451

  5. Radiologic response to transcatheter hepatic arterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma

    Liver International

    Volume 34, Issue 2, February 2014, Pages: 305–312, Chang Joon Kim, Hong Joo Kim, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim and Min-Ji Kim

    Version of Record online : 25 JUL 2013, DOI: 10.1111/liv.12270

  6. Safety and efficacy of transarterial chemoembolization in patients with transjugular intrahepatic portosystemic shunts

    HPB

    Volume 17, Issue 8, August 2015, Pages: 707–712, John T. Miura, William S. Rilling, Sarah B. White, Robert A. Hieb, Sean M. Tutton, Parag J. Patel, T. Clark Gamblin and Eric J. Hohenwalter

    Version of Record online : 14 JUL 2015, DOI: 10.1111/hpb.12433

  7. You have free access to this content
    Dynamic changes of the inflammation-based index predict mortality following chemoembolisation for hepatocellular carcinoma: a prospective study

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 11-12, December 2014, Pages: 1270–1281, D. J. Pinato, G. Karamanakos, T. Arizumi, D. Adjogatse, Y. W. Kim, J. Stebbing, M. Kudo, J. W. Jang and R. Sharma

    Version of Record online : 18 OCT 2014, DOI: 10.1111/apt.12992

  8. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study

    Journal of Magnetic Resonance Imaging

    Volume 42, Issue 4, October 2015, Pages: 981–989, Nima Kokabi, Juan C. Camacho, Minzhi Xing, Faramarz Edalat, Pardeep K. Mittal and Hyun S. Kim

    Version of Record online : 12 FEB 2015, DOI: 10.1002/jmri.24845

  9. Predictors of repeat transarterial chemoembolization in the treatment of hepatocellular carcinoma

    HPB

    Volume 16, Issue 12, December 2014, Pages: 1095–1101, Jared A. White, David T. Redden, Mary Kate Bryant, David Dorn, Souheil Saddekni, Ahmed Kamel Abdel Aal, Jessica Zarzour, David Bolus, J. Kevin Smith, Stephen Gray, Devin E. Eckhoff and Derek A. DuBay

    Version of Record online : 26 AUG 2014, DOI: 10.1111/hpb.12313

  10. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  11. Correlation of tumor response on computed tomography with pathological necrosis in hepatocellular carcinoma treated by chemoembolization before liver transplantation

    Liver Transplantation

    Volume 22, Issue 11, November 2016, Pages: 1491–1500, Marco Dioguardi Burgio, Maxime Ronot, Onorina Bruno, Claire Francoz, Valérie Paradis, Laurent Castera, François Durand, Olivier Soubrane and Valérie Vilgrain

    Version of Record online : 26 OCT 2016, DOI: 10.1002/lt.24615

  12. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma

    Liver International

    Volume 34, Issue 4, April 2014, Pages: 612–620, Gao Heng-jun, Zhang Yao-jun, Chen Min-shan, Chen Mei-xian, Huang Jun-ting, Xu Li and Wan Y. Lau

    Version of Record online : 13 SEP 2013, DOI: 10.1111/liv.12307

  13. Serum cell death biomarker mirrors liver cancer regression after transarterial chemoembolisation

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 7, October 2016, Pages: 747–754, B. Bock, D. Hasdemir, F. Wandrer, T. Rodt, M. P. Manns, K. Schulze-Osthoff and H. Bantel

    Version of Record online : 3 AUG 2016, DOI: 10.1111/apt.13758

  14. Best radiological response to trans-arterial chemoembolization for hepatocellular carcinoma does not imply better outcomes

    HPB

    Volume 15, Issue 3, March 2013, Pages: 196–202, Jon C. Henry, Lavina Malhotra, Hooman Khabiri, Gregory Guy, Anthony Michaels, James Hanje, Marcela Azevedo, Mark Bloomston and Carl R. Schmidt

    Version of Record online : 28 AUG 2012, DOI: 10.1111/j.1477-2574.2012.00529.x

  15. Chemoembolization outcomes for hepatocellular carcinoma in cirrhotic patients with compromised liver function

    HPB

    Volume 16, Issue 7, July 2014, Pages: 648–655, David P. Dorn, Mary K. Bryant, Jessica Zarzour, J. Kevin Smith, David T. Redden, Souheil Saddekni, Ahmed Kamel Abdel Aal, Stephen Gray, Jared White, Devin E. Eckhoff and Derek A. DuBay

    Version of Record online : 20 NOV 2013, DOI: 10.1111/hpb.12194

  16. You have free access to this content
    Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib

    Hepatology

    Volume 58, Issue 5, November 2013, Pages: 1655–1666, Michael Vouche, Laura Kulik, Rohi Atassi, Khairuddin Memon, Ryan Hickey, Daniel Ganger, Frank H. Miller, Vahid Yaghmai, Michael Abecassis, Talia Baker, Mary Mulcahy, Ritu Nayar, Robert J. Lewandowski and Riad Salem

    Version of Record online : 1 OCT 2013, DOI: 10.1002/hep.26487

  17. Radiological–pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgery

    Journal of Gastroenterology and Hepatology

    Volume 31, Issue 9, September 2016, Pages: 1619–1627, Jun Won Kim, Jinsil Seong, Mi Sook Park, Kyung Sik Kim, Young Nyun Park, Kwang Hyub Han, Ki Chang Keum and Ik Jae Lee

    Version of Record online : 25 SEP 2016, DOI: 10.1111/jgh.13334

  18. Response to transarterial chemoembolization as a selection criterion for resection of hepatocellular carcinomas

    British Journal of Surgery

    Volume 103, Issue 7, June 2016, Pages: 881–890, J. Y. Lei, J. J. Zhong, L. N. Yan, J. Q. Zhu, W. T. Wang, Y. Zeng, B. Li, T. F. Wen, J. Y. Yang and – Liver Surgery Group

    Version of Record online : 30 MAR 2016, DOI: 10.1002/bjs.9864

  19. Computed tomography predictors of hepatocellular carcinoma tumour necrosis after chemoembolization

    HPB

    Volume 16, Issue 4, April 2014, Pages: 327–335, Mary K. Bryant, David P. Dorn, Jessica Zarzour, J. Kevin Smith, David T. Redden, Souheil Saddekni, Ahmed Kamel Abdel Aal, Stephen H. Gray, Devin E. Eckhoff and Derek A. DuBay

    Version of Record online : 26 AUG 2013, DOI: 10.1111/hpb.12149

  20. You have free access to this content
    Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 1, January 2015, Pages: 126–136, D. Bettinger, E. Knüppel, W. Euringer, H. C. Spangenberg, M. Rössle, R. Thimme and M. Schultheiß

    Version of Record online : 20 OCT 2014, DOI: 10.1111/apt.12994